Orexo
Orexo: Zubsolv solidly maintains market share (Redeye)

2021-01-20 16:30
Redeye updates the market share data for Zubsolv. Zubsolv maintains market share in terms of prescriptions, number of tablets sold, and dollar value of the total market. This looks sustainable to us.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Orexo - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -